For 20 sites, men had increased odds of being diagnosed with cancer at regional and/or distant stages versus localized stage.

Patients exposed to vitamin D showed significantly longer treatment-free survival than nonusers, with median durations of 147 vs 82 months.

Detection of KRAS-mutant ctDNA by both NGS, ddPCR associated with shorter overall survival. HealthDay News — KRAS-mutant circulating tumor (ct)DNA is associated with worse overall survival (OS) in ...

Outpatient monitoring of CAR T-cell therapy reduces healthcare resource utilization and hospital days without impacting 30-day mortality, finds ASCO study.

In the phase 3 SUBITO trial, researchers aimed to compare outcomes with intensified alkylating chemotherapy to those with an HRD-targeting regimen.

Using individual patient data from phase 2 and 3 trials, investigators analyzed the value of pathologic complete response vs ctDNA clearance after neoadjuvant immunotherapy or perioperative ...

PVR demonstrated superiority versus VR in the ITT analysis population; benefits consistent across prespecified subgroups.

A real-world analysis investigates the impact of concurrent GLP-1 RA use on long-term survival and the safety profile of patients with solid and hematologic malignancies receiving immune checkpoint ...

In this study, researchers aimed to evaluate patterns of engagement with health-related content on social media among US adults both with and without chronic conditions.

Early low-dose lenalidomide significantly reduces mutational burden without increasing AML risk in non-transfusion-dependent del(5q) MDS.

Investigators conducted a retrospective analysis to determine whether postmenopausal women with a history of breast cancer can safely receive vaginal estrogen.

Low MAR consistently identified patients with more favorable long-term outcomes across subgroups. Preoperative monocyte-to-albumin ratio (MAR) independently predicted overall survival (OS) in patients ...